Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 22, 2019
Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastasesNicholas Osborne, Rebecca Sundseth, Martha D Gay, et al.Cancer Biology & Therapy|January 27, 2012
A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancerJill P Smith, John F Harms, Gail L Matters, et al.Anti-Cancer Drugs|March 12, 2004
Treatment of advanced pancreatic cancer with opioid growth factor: phase IJill P Smith, Robert L Conter, Sandra I Bingaman, et al.Digestive Diseases and Sciences|July 13, 2019
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular CarcinomaRobin D Tucker, Victor Ciofoaia, Sandeep Nadella, et al.Pancreas|April 20, 2023
Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer?Matthew A Huber, Sandeep Nadella, Hong Cao, et al.ACS Nano|February 26, 2010
Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivoBrian M Barth, Rahul Sharma, Erhan I Altinoğlu, et al.Pancreas|May 26, 2009
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expressionGail L Matters, John F Harms, Christopher O McGovern, et al.Nucleic Acid Therapeutics|October 19, 2016
A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal AdenocarcinomaGary A Clawson, Thomas Abraham, Weihua Pan, et al.Cancer Investigation|April 8, 2025
A Phase I Study of the Naturally Occurring Bioactive, Opioid Growth Factor, in Patients with Unresectable Hepatocellular CancerEric T Kimchi, Jussuf T Kaifi, Yixing Jiang, et al.ACS Nano|February 5, 2013
PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphateBrian M Barth, Sriram S Shanmugavelandy, James M Kaiser, et al.Pageof 7